share_log

Oppenheimer Upgrades AngioDynamics to Outperform, Announces $12 Price Target

Moomoo 24/7 ·  Apr 5 08:40

Oppenheimer analyst Steven Lichtman upgrades AngioDynamics (NASDAQ:ANGO) from Perform to Outperform and announces $12 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment